Accessibility Menu
Haleon Plc logo

Haleon Plc(LSE) HLN

Market Cap£32.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+24%
5 YearN/A
1 Year+5%
1 Month+2%
£3.66
+2.24%
+0.08Today
Haleon Plc last closing stock price
MetricPriceDate
Last closeGBX 365.702026-08-05
Haleon Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.69%GBX 379.702026-07-29
1 month+2.01%GBX 358.502026-07-06
3 month+9.13%GBX 335.102026-05-07
Year to date-2.43%GBX 374.802025-12-31
1 year+4.55%GBX 349.802025-08-05
3 year+13.66%GBX 321.752023-08-04
Since inception+23.54%GBX 2.902022-07-18

Haleon Plc Financials at a Glance

Market Cap

£32.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£11.03B

Net Income (TTM)

£1.67B

EPS (TTM)

£0.18

P/E Ratio

20.08

Dividend

£0.07

Beta (Volatility)

-0.10 (Low)

Price

£3.66

Volume

16,891,845

Open

£3.61

Previous Close

£3.66

Daily Range

£3.61 - £3.67

52-Week Range

£3.18 - £4.16

Estimated Earnings Date

Mar 4, 2027

HLN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haleon Plc

Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. The company offers a comprehensive selection of items, including therapeutic oral care, pain relief solutions, respiratory health aids, and dietary supplements.

Products and Services
  • Prominent brands include Panadol, Voltaren, and Sensodyne
  • Offers a range of vitamins, minerals, and dietary supplements
  • Specializes in pain relief and digestive wellness products
Growth Outlook
  • Revenue of £2.775 billion in Q4 2025, showing consistent growth
  • Operating income margin of 21.78% indicates strong operational efficiency
  • Net income of £430.5 million in Q4 2025 reflects robust profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of £10.8 billion demonstrates solid performance
  • Dividend yield of 1.94% offers attractive returns to shareholders
  • Current ratio of 0.92 suggests effective management of short-term liabilities
Haleon plc, incorporated in 2021, has quickly established itself in the consumer health sector. The company operates across multiple continents, including North America, Europe, and Asia Pacific, allowing for a diverse market presence. The extensive product portfolio, featuring well-known brands, positions Haleon favorably in the competitive landscape. Recent financial performance indicates a strong growth trajectory, with significant revenue and net income figures. The company's focus on operational efficiency is reflected in its healthy operating income margin. With a commitment to innovation and consumer health, Haleon presents a compelling opportunity for potential investors.
AI Generated • Aug 6, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Brian James McNamara, MBA

Website

www.haleon.com

Headquarters

Weybridge, SU KT13 0NY, GB

HLN Financials

Key Financial Metrics (TTM)

Gross Margin

64.77%

Operating Margin

21.87%

Net Income Margin

15.11%

Return on Equity

10.30%

Return on Capital

9.89%

Return on Assets

5.11%

Earnings Yield

4.98%

Dividend Yield

1.94%

Payout Ratio

36.71%

Stock Overview

Market Cap

£32.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.81B

Volume

16.89M

Avg. Volume

23.32M

Financials (TTM)

Gross Profit

£7.14B

Operating Income

£2.41B

EBITDA

£2.80B

Operating Cash Flow

£1.51B

Capital Expenditure

-£322.00M

Free Cash Flow

£1.18B

Cash & ST Invst.

£1.32B

Total Debt

£8.58B

Haleon Plc Performance Analysis

Haleon Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 10,858,000,00013.8%
20232023-12-31GBP 11,302,000,0004.1%
20242024-12-31GBP 11,233,000,000-0.6%
20252025-12-31GBP 11,030,000,000-1.8%
Haleon Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-0.7%
Q22025-06-30N/A
Q32025-09-301.3%
Q42025-12-31N/A
Haleon Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.11-23.7%
20232023-12-31GBP 0.11-1.4%
20242024-12-31GBP 0.1638.9%
20252025-12-31GBP 0.1817.5%
Haleon Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3176.6%
Q22025-06-30N/A
Q32025-09-307.9%
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£2.78B

+0.6%

Gross Profit

£1.80B

+18.1%

Gross Margin

65.03%

N/A

Market Cap

£32.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£1.31M

N/A

Employees

24,535

N/A

Net Income

£430.50M

+86.4%

EBITDA

£704.50M

+3.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£1.32B

-39.7%

Total Debt

£8.58B

-15.0%

Accounts Receivable

£2.12B

+11.5%

Inventory

£1.03B

-13.9%

Long Term Debt

£7.75B

-10.1%

Short Term Debt

£836.00M

-43.8%

Return on Assets

5.11%

N/A

Return on Invested Capital

8.71%

N/A

Free Cash Flow

£126.50M

N/A

Operating Cash Flow

£239.50M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SN.LSmith & Nephew plc
£11.09-1.20%
HIK.LHikma Pharmaceuticals PLC
£15.71-0.63%
HCM.LHUTCHMED (China) Limited
£1.78+2.89%
AGY.LAllergy Therapeutics plc
£0.05-4.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.27-0.14%
NVDANvidia
$219.22+0.03%
ONDSOndas
$8.87+0.00%
PATHUiPath
$13.82-0.02%

Questions About HLN

What is the current price of Haleon Plc?

Haleon Plc is trading at £3.66 per share.

What is the 52-week range for Haleon Plc?

Over the past 52 weeks, Haleon Plc has traded between £3.18 and £4.16.

How much debt does Haleon Plc have?

As of the most recent reporting period, Haleon Plc reported total debt of £8.61B.

How much cash does Haleon Plc have on hand?

Haleon Plc reported £1.32B in cash and cash equivalents in its most recent financial results.

What is Haleon Plc’s dividend yield?

Haleon Plc currently has a dividend yield of 1.94%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services